Header

UZH-Logo

Maintenance Infos

Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab


Hanfstingl, Kathrin; Pekar-Lukacs, Agnes; Motz, Reinhard; Guenova, Emmanuella; Hoetzenecker, Wolfram (2018). Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab. Case Reports in Dermatology, 10(2):97-100.

Abstract

Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause and often confounded with psoriasis. It is characterised by hyperkeratotic follicular papules, scaly erythematous plaques, palmoplantar keratoderma, and a progression to generalised erythroderma. Here, we report the case of a 68-year-old man with pityriasis rubra pilaris, who was successfully treated with ixekizumab, an interleukin-17A inhibitor.

Abstract

Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause and often confounded with psoriasis. It is characterised by hyperkeratotic follicular papules, scaly erythematous plaques, palmoplantar keratoderma, and a progression to generalised erythroderma. Here, we report the case of a 68-year-old man with pityriasis rubra pilaris, who was successfully treated with ixekizumab, an interleukin-17A inhibitor.

Statistics

Citations

Dimensions.ai Metrics
16 citations in Web of Science®
14 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

56 downloads since deposited on 18 Jan 2019
7 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Dermatology
Language:English
Date:2 May 2018
Deposited On:18 Jan 2019 14:06
Last Modified:21 Sep 2023 01:36
Publisher:Karger
ISSN:1662-6567
OA Status:Gold
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1159/000488902
PubMed ID:29867429
  • Content: Published Version
  • Licence: Creative Commons: Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)